Article Name Clinical & Diagnostic
Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing The Need For Casting And Surgical Intervention
17th January, 2024
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.
08th January, 2024
Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets by 2030.
08th January, 2024
Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.
05th January, 2024
Groundbreaking Solution Identifies Undiagnosed AFib and Speeds Treatments Proven to Prevent Strokes
18th December, 2023
The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW's State-of-the-Art Technology for the Safe Management of Frozen Eggs and Embryos Providing a New Standard of Care for Fertility Patients
18th December, 2023
For the 4 in 10 U.S. adults living with obesity, and therefore at increased risk of heart disease,1 Optifast is a non-invasive option to potentially lose weight and preserve heart health
18th December, 2023
EONIS Q System enabling faster, simplified newborn screening for SMA and SCID
11th December, 2023
Enabling People to Overcome Foot Ulcer Through Self-Care: Varco® Leg Care Launches First-of-its-Kind Ulcer Treatment Product
07th December, 2023
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
04th December, 2023
Company Committed to Support U.S. Health Care Needs
04th December, 2023
With An Array Of Products In The Portfolio; ICPA Eyes 14% Of The Interdental Products Market Valued Around Rs.200 Cr
20th November, 2023
Apollo, the world's largest integrated healthcare provider, completed 25 years of liver transplant program in India with over 4300 liver transplants, including 515 in children from over 50 countries. Today, Apollo performs more than 1600 solid organ transplants a year. With 90% success rates, The Apollo Liver Transplant program is a beacon of quality and hope for patients from across the world.
16th November, 2023
Roche announced the launch of the Elecsys®Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV) infections in countries accepting the CE mark. By testing for HEV infection, clinicians can support their patients to identify the cause of their symptoms and determine appropriate treatment, monitor for progression to severe acute HEV and prevent severe disease progression with antiviral treatment.1,2,6
16th November, 2023
Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, recently announced the launch of Occlusafe™ and LifePearl™, intended for use in the management of Liver Cancer.
13th November, 2023
New agreement will focus on a specific type of cancer
09th November, 2023
Kauvery Hospital Main, Alwarpet, a leading healthcare institution, is pleased to announce a successful life-saving pulmonary endarterectomy surgery on a 49-year-old patient suffering from heart failure due to severe Chronic Thromboembolic Pulmonary Hypertension (CTEPH). The surgical procedure, carried out by the expert medical team under the leadership of Dr. Kumud Dhital, Director of the Cardiovascular & Thoracic Surgery Department & Heart-Lung Transplantation Unit, is a notable achievement in the hospital’s dedication to offering state-of-the-art healthcare and advanced medical therapies.
07th November, 2023
Anticipates a significant revenue boost of Rs 40 million
06th November, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer